The selective glycine antagonist gavestinel lacks phencyclidine-like behavioral effects

Behavioural Pharmacology

Volumn 13, Issue 7, 2002, Pages 583-592

  Beardsley, Patrick M ^a   Ratti, E ^b   Balster, R L ^a   Willetts, J ^c   Trist, D ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GLAXOSMITHKLINE   (United States)

^c Palanquin Corporation   (United States)

Author keywords

Drug discrimination; Drug self administration; Gavestinel; Glycine antagonist; GV150526A; NMDA antagonist; Phencyclidine; Rat; Rhesus monkey

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BETA CYCLODEXTRIN; DRUG VEHICLE; GAVESTINEL; GLYCINE; GLYCINE RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENCYCLIDINE; SODIUM CHLORIDE; STRYCHNINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG DISCRIMINATION; DRUG EFFECT; DRUG INFUSION; DRUG SCREENING; DRUG SELF ADMINISTRATION; FEMALE; FOOD; MALE; NONHUMAN; RAT; REINFORCEMENT; RHESUS MONKEY; TRAINING; TREATMENT OUTCOME;

EID: 0036854917     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200211000-00007     Document Type: Article

References (32)

1. Ator NA, Griffiths RR (1987). Self-administration of barbiturates and benzodiazepines: A review. Pharmacol Biochem Behav 27:391-398.
2. Badini I, Beani L, Bianchi C, Marzola G, Siniscalchi A (1997). Post-ischemic recovery of acetylcholine release in vitro: Influence of different excitatory amino acid receptor subtype antagonists. Neurochem Int 31:817-824.
3. Balster RL, Lukas SE (1985). Review of self-administration. Drug Alcohol Depend 14:249-261.
4. Balster RL, Mansbach RS, Shelton KL, Nicholson KL, Grech DM, Wiley JL et al. (1995). Behavioral pharmacology of two novel substituted quinoxalinedione glutamate antagonists. Behav Pharmacol 6:577-589.
5. Baron SP, Woods JH (1995). Competitive and uncompetitive N-methyl-d-aspartate antagonist discriminations in pigeons: CGS 19755 and phencyclidine. Psychopharmacology (Berl) 118:42-51.
6. Beardsley PM, Hayes BA, Balster RL (1990). The self-administration of MK-801 can depend upon drug-reinforcement history, and its discriminative stimulus properties are phencyclidine-like in rhesus monkeys. J Pharmacol Exp Ther 252:953-959.
7. Bordi F, Pietra C, Ziviani L, Reggiani A (1997). The glycine antagonist GV150526 protects somatosensory evoked potentials and reduces the infarct area in the MCAO model of focal ischemia in the rat. Exp Neurol 145:425-433.
8. Bordi F, Terron A, Reggiani A (1999). The neuroprotective glycine receptor antagonist GV150526 does not produce neuronal vacuolization or cognitive deficits in rats. Eur J Pharmacol 378:153-160.
9. Carter AJ (1992). Glycine antagonists: Regulation of the NMDA receptor-channel complex by the strychnine-insensitive glycine site. Drugs of the Future 17:595-613.
10. Davis SM, Lees KR, Albers GW, Diener HC, Markabi S, Karlsson G, Norris J (2000). Selfotel in acute ischemic stroke. Possible neurotoxic effects of an NMDA antagonist. Stroke 31:347-354.
11. Di Fabio R, Capelli AM, Conti N, Cugola A, Donati D, Feriani A et al. (1997). Substituted indole-2-carboxylates as in vivo potent antagonists acting as the strychnine-insensitive glycine binding site. J Med Chem 40:841-850.
12. Di Fabio R Conti N, De Magistris E, Feriani A, Provera S, Sabbatini FM, et al. (1999). Substituted analogues of GV150526 as potent glycine binding site antagonists in animal models of cerebral ischemia. J Med Chem 42:3486-3493.
13. Dyker AG, Edwards KR, Fayad PB, Hormes JT, Lees KR (1999). Safety and tolerability of aptiganel hydrochloride in patients with acute ischemic stroke. Stroke 30:2038-2042.
14. Geter-Douglass B, Witkin JM (1997). Dizocilpine-like discriminative stimulus effects of competitive NMDA receptor antagonists in mice. Psychopharmacology 133:43-50.
15. Johanson CE, Balster RL (1978). A summary of results of a drug self-administration study using substitution procedures in rhesus monkeys. Bull Narc 30:43-54.
16. Koek W, Colpaert FC (1990). Selective blockade of N-methyl-d-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: Relationship with phencyclidine-like behavioral effects. J Pharmacol Exp Ther 252:349-357.
17. Koek W, Woods JH, Winger G (1988). MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J Pharmacol Exp Ther 245:963-974.
18. Lees KR, Lavelle JF, Cunha L, Diener HC, Sanders EACM, Tack P, Wester P (2001). Glycine antagonist (GV150526) in acute stroke: A multicentre, double-blind placebo-controlled phase II trial. Cerebrovasc Dis 11:20-29.
19. 3H]dopamine release. Eur J Pharmacol 336:275-281.
20. 3H]GV150526A in rat cerebral cortical membranes. Eur J Pharmacol 391:233-241.
21. Nicholson KL, Jones HE, Balster RL (1997). Evaluation of the reinforcing and discriminative stimulus effects of the N-methyl-d-aspartate competitive antagonist NPC 17742 in rhesus monkeys. Behav Pharmacol 8:396-407.
22. Nicholson KL, Jones HE, Balster RL (1998). Evaluation of the reinforcing and discriminative stimulus properties of the low-affinity N-methyl-d-aspartate channel blocker memantine. Behav Pharmacol 9:231-243.
23. Nicholson KL, Hayes BA, Balster RL (1999). Evaluation of the reinforcing properties and phencyclidine-like discriminative stimulus effects of dextromethorphan and dextrorphan in rats and rhesus monkeys. Psychopharmacology 146:49-59.
24. Preston KL, Bigelow GE (1991). Subjective and discriminative effects of drugs. Behav Pharmacol 2:293-313.
25. Sacco RL, DeRosa JT, Haley EC Jr, Levin B, Ordronneau P, Phillips SJ et al. (2001). Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: A randomized controlled trial. JAMA 285:1719-1728.
26. Schuster CR, Johanson CE (1988). Relationship between the discriminative stimulus properties and subjective effects of drugs. In: Transduction Mechanisms of Drug Stimuli. Colpaert FC, Balster RL (editors). Berlin: Springer-Verlag. pp. 161-175.
27. Singh L, Menzies R, Tricklebank MD (1990). The discriminative stimulus properties of (+)-HA-966, an antagonist at the glycine/N-methyl-d-aspartate receptor. Eur J Pharmacol 186:129-132.
28. ++ in primary cultured cerebral cortical cells. Neurochem Int 32:345-351.
29. Willetts J, Balster RL, Leander D (1990). The behavioral pharmacology of NMDA receptor antagonists. Trends Pharmacol Sci 11:423-428.
30. Willetts J, Morse WH, Lee-Parritz D (1992). Behavioral pharmacology of NMDA antagonists. In Excitatory Amino Acids, Fidia Research Foundation Symposium Series Volume 9. Simon RP (editor). New York: Thieme Medical Publishers, pp. 203-209.
31. Winger G, France CP, Woods JH (1991). Intravenous self-injection in rhesus monkeys. In Excitatory Amino Acids, Fidia Research Foundation Symposium Series Volume 5. Meldrum BS, Moroni F, Simon RP (editors). New York: Raven Press, pp. 539-545.
32. Witkin JM, Steel TD, Sharpe LG (1997). Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline. J Pharmacol Exp Ther 280:46-52.